Literature DB >> 32029068

Factors related to positive airway pressure therapy adherence in children with obesity and sleep-disordered breathing.

Sherri L Katz1,2, Valerie G Kirk3, Joanna E MacLean4, Glenda N Bendiak3, Mary-Ann Harrison2, Nicholas Barrowman2, Lynda Hoey2, Linda Horwood5, Stasia Hadjiyannakis1, Laurent Legault5, Bethany J Foster5, Evelyn Constantin5.   

Abstract

STUDY
OBJECTIVES: Positive airway pressure (PAP) is used to treat children with concurrent obesity and sleep-disordered breathing (SDB), but achieving adherence remains challenging. We aimed to identify factors associated with PAP adherence in a prospective cohort of children with obesity prescribed PAP for newly diagnosed SDB.
METHODS: A questionnaire to assess factors related to PAP adherence was administered to participants and their parent ≥12 months after enrollment. Adherence (PAP use ≥4 hours/night on >50% of nights) was measured with PAP machine downloads, diaries, and physician assessments. Questionnaire responses were compared between adherent/nonadherent participants and between children/parents. Age, total and obstructive apnea-hypopnea index (OAHI), lowest oxygen saturation, and highest carbon dioxide were compared between adherent/nonadherent children with univariate differences of medians, with 95% confidence intervals.
RESULTS: Fourteen children (median age: 14.3 years; 93% male; all with obstructive sleep apnea) were included. Eleven (79%) were adherent to PAP. SDB symptom improvement was reported in 9 of 14 children (64%); 8 of 14 children (57%) had positive experiences with PAP. Most children assumed an active role in PAP initiation and felt supported by the clinical team. Responses between adherent/nonadherent groups and between children/parents were similar. Oxygen saturation nadir (median difference between nonadherent and adherent groups: 8.9%; 95% confidence interval: 1.7, 16.1), but not age, apnea-hypopnea index, OAHI, or maximum carbon dioxide, was associated with PAP adherence.
CONCLUSIONS: Children with obesity-related SDB with lower nocturnal oxygen saturation nadir were more likely to adhere to PAP therapy. Ensuring adequate understanding of PAP therapy and medical team support are key factors in PAP success.
© 2020 American Academy of Sleep Medicine.

Entities:  

Keywords:  CPAP; adherence; children; noninvasive ventilation; obesity; obstructive sleep apnea; positive airway pressure; qualitative; sleep-disordered breathing; treatment

Year:  2020        PMID: 32029068      PMCID: PMC7849790          DOI: 10.5664/jcsm.8336

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  33 in total

Review 1.  Behavioural and neurocognitive implications of snoring and obstructive sleep apnoea in children: facts and theory.

Authors:  Louise M O'Brien; David Gozal
Journal:  Paediatr Respir Rev       Date:  2002-03       Impact factor: 2.726

2.  Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements.

Authors:  Douglas G Bonett; Robert M Price
Journal:  Psychol Methods       Date:  2002-09

Review 3.  Cardiovascular complications of obstructive sleep apnea syndrome: evidence from children.

Authors:  Rakesh Bhattacharjee; Leila Kheirandish-Gozal; Giora Pillar; David Gozal
Journal:  Prog Cardiovasc Dis       Date:  2009 Mar-Apr       Impact factor: 8.194

4.  Compliance with noninvasive home ventilation in children with obstructive sleep apnoea.

Authors:  Anna Maria Nathan; Jenny Poh Lin Tang; Anne Goh; Oon Hoe Teoh; Oh Moh Chay
Journal:  Singapore Med J       Date:  2013-12       Impact factor: 1.858

5.  Compliance rates in children using noninvasive continuous positive airway pressure.

Authors:  Anne R O'Donnell; Candice L Bjornson; Shelly G Bohn; Valerie G Kirk
Journal:  Sleep       Date:  2006-05       Impact factor: 5.849

6.  Patterns of continuous positive airway pressure adherence during the first 3 months of treatment in children.

Authors:  Gillian M Nixon; Rebecca Mihai; Nicole Verginis; Margot J Davey
Journal:  J Pediatr       Date:  2011-05-20       Impact factor: 4.406

7.  Quality of Life in Youth With Obstructive Sleep Apnea Syndrome (OSAS) Treated With Continuous Positive Airway Pressure (CPAP) Therapy.

Authors:  Mary K Lynch; Lindsey C Elliott; Kristin T Avis; David C Schwebel; Burel R Goodin
Journal:  Behav Sleep Med       Date:  2017-05-30       Impact factor: 2.964

8.  Self-Efficacy and Short-Term Adherence to Continuous Positive Airway Pressure Treatment in Children.

Authors:  Melissa S Xanthopoulos; Ji Young Kim; Michael Blechner; Ming-Yu Chang; Mary Kate Menello; Christina Brown; Edward Matthews; Terri E Weaver; Justine Shults; Carole L Marcus
Journal:  Sleep       Date:  2017-07-01       Impact factor: 5.849

9.  Insulin Resistance and Hypertension in Obese Youth With Sleep-Disordered Breathing Treated With Positive Airway Pressure: A Prospective Multicenter Study.

Authors:  Sherri L Katz; Joanna E MacLean; Lynda Hoey; Linda Horwood; Nicholas Barrowman; Bethany Foster; Stasia Hadjiyannakis; Laurent Legault; Glenda N Bendiak; Valerie G Kirk; Evelyn Constantin
Journal:  J Clin Sleep Med       Date:  2017-09-15       Impact factor: 4.062

10.  Pediatric Positive Airway Pressure Adherence in Obstructive Sleep Apnea Enhanced by Family Member Positive Airway Pressure Usage.

Authors:  Pooja Puri; Kristie R Ross; Reena Mehra; James C Spilsbury; Hong Li; Carolyn E Levers-Landis; Carol L Rosen
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

View more
  2 in total

1.  How adherent are obese children with sleep-disordered breathing on positive airway pressure therapy?

Authors:  Sanjeev V Kothare; Kristin Kelly-Pieper
Journal:  J Clin Sleep Med       Date:  2020-03-25       Impact factor: 4.062

2.  A social media intervention for the families of young Black men with obstructive sleep apnoea.

Authors:  Alexa J Watach; Chanelle T Bishop-Gilyard; Helen Ku; Olufunke Afolabi-Brown; Elizabeth Prout Parks; Melissa S Xanthopoulos
Journal:  Health Educ J       Date:  2022-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.